Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities



Status:Active, not recruiting
Conditions:Breast Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:25 - Any
Updated:3/15/2019
Start Date:March 2015
End Date:March 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Contrast Enhanced Spectral Mammography (CESM) is an advanced form of mammography which is
performed after injection of contrast or dye into a vein in the arm. This dye is the same dye
that is used for CT scans. This type of mammogram includes a regular mammogram as well as
additional pictures with the dye.

This particular study is being done to determine if by adding the dye in the veins the
investigators are better able to identify the cause of the lump than if they just did the
regular mammogram alone.


Inclusion Criteria:

- Women presenting for mammographic evaluation of an undiagnosed palpable mass found
either by self examination and/or examination by referring physician

Exclusion Criteria:

- Age < 25 years old

- Male patients

- Pregnant or lactating patients

- Patients with allergy to iodinated contrast

- Patients with a history of renal disease or patients over 70 with a creatinine > 1.3.
Creatinine must have been done within the last 12 weeks.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Maxine Jochelson, MD
Phone: 646-888-4507
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials